The effect of resistant starch and nutriose FM06 supplementation in type 2 diabetes

The effect of resistant starch and nutriose FM06 supplementation on antioxdant status, metabolic and inflammatory factors in type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201110293253N5

Enrollment

Registered

2012-01-25

Start date

2012-01-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. Endocrine, nutritional and metabolic diseases

Interventions

Intervention 1: Intervention group1: resistant starch powder 10 g (2*5 gr)/d, divided into 2 portions of 5g each to be eaten during breakfast and dinner, for two months. Intervention 2: Intervention g

Treatment - Other

Intervention group1: resistant starch powder 10 g (2*5 gr)/d, divided into 2 portions of 5g each to be eaten during breakfast and dinner, for two months

Intervention group2: nutriose FM06 powder 10 g (2*5 gr)/d, divided into 2 portions of 5g each to be eaten during breakfast and dinner, for two months

Placebo group: dextrin maltose 10 g (2*5 gr)/d, divided into 2 portions of 5g each to be eaten during breakfast and dinner, for two months

Eligibility

Sex/Gender

Female

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 30-65 years old, 25= BMI <35, having diabetes at least 6 months prior to the study, consumption of blood glucose lowering drug,. typical ?ber intake <25 g ?ber/d Exclusion criteria: consumption of antioxidants supplements during last 3 months prior to the study, using insulin, pregnancy, lactation, acute renal disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Dietary intake. Timepoint: 8 week. Method of measurement: 24 hours-food recal questionnaire.;Serum antioxidant status. Timepoint: 8 week. Method of measurement: measurement of SOD,GPX-H,TAC,MDA.;Lipid profiles. Timepoint: 8 week. Method of measurement: TC, TG, LDL, HDL.;Insulin level. Timepoint: 8 week. Method of measurement: Serum level of fasting insulin.;Blood glucose & HbA1c. Timepoint: 8 week. Method of measurement: fasting blood glucose & HbA1c.;Inflammatory factors. Timepoint: 8 week. Method of measurement: HS-CRP,TNF-a,IL-6.	—

Measure

Time frame

Dietary intake. Timepoint: 8 week. Method of measurement: 24 hours-food recal questionnaire.;Serum antioxidant status. Timepoint: 8 week. Method of measurement: measurement of SOD,GPX-H,TAC,MDA.;Lipid profiles. Timepoint: 8 week. Method of measurement: TC, TG, LDL, HDL.;Insulin level. Timepoint: 8 week. Method of measurement: Serum level of fasting insulin.;Blood glucose & HbA1c. Timepoint: 8 week. Method of measurement: fasting blood glucose & HbA1c.;Inflammatory factors. Timepoint: 8 week. Method of measurement: HS-CRP,TNF-a,IL-6.

—

Secondary

Measure	Time frame
Appetite. Timepoint: 8week. Method of measurement: questionnaire.;Anthropomethric indices. Timepoint: 8week. Method of measurement: Weight, Height, WB,WHR.;Blood pressure. Timepoint: 8 week. Method of measurement: blood pressure.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Bahram Pourghasem gharghari

Nutritional Research Center, Tabriz University Of Medical Sciences

pourghassemb@tbzmed.ac.ir+98 41 1334 1113

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026